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Summary 
Background 
Physiological measures of heart failure (HF) are common in surgical patients, despite the 
absence of a formal diagnosis. Heart rate increases during exercise are frequently blunted 
in HF (termed chronotropic incompetence (CI)), which primarily reflects beta-
adrenoreceptor dysfunction. We examined whether CI was associated with myocardial 
injury after non-cardiac surgery. 
 
Methods 
Pre-defined analysis of an international cohort study where participants aged ≥40 years 
underwent symptom-limited cardiopulmonary exercise testing before non-cardiac 
surgery. CI was defined as the ratio of increase in heart rate during exercise to age-
predicted maximal increase in heart rate <0.6 (with/without rate-limiting medication). 
The primary outcome was myocardial injury within 3 days after surgery, defined by high-
sensitivity troponin assays (I/T) >99th centile. Explanatory variables were biomarkers for 
HF (VE/VCO2≥34; VO2peak≤14ml kg min-1; heart rate recovery (HRR) ≤6 beats minute-
1 one minute post-exercise; preoperative NTpro-BNP >300pg mL-1). Myocardial injury 
was compared in presence/absence of sympathetic (CI)/parasympathetic (HRR) 
thresholds indicative of dysfunction. Data are presented as odds ratios [OR] (95% 
confidence intervals). 
 
Results  
CI occurred in 396/1325 (29.9%) participants; 16/1325 (1.2%) had a formal HF 
diagnosis. 162/1325 (12.2%) patients sustained myocardial injury. Raised NTpro-BNP 
(indicative of HF) was more common when CI<0.6 (OR 1.57 [1.11-2.23];p<0.01). CI 
was not associated with myocardial injury (OR: 1.05 [0.74-1.50]; p=0.78), independent 
of rate-limiting therapy. HRR<12 beats minute-1 was associated with myocardial injury 
in the presence (OR:1.62 [1.05-2.51];p=0.03) or absence (OR:1.60 [1.06-2.39];p=0.02) 
of CI. 
 
Conclusions 
Chronotropic incompetence is common in surgical patients. In contrast to 
parasympathetic dysfunction, CI is not associated with myocardial injury. 
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Introduction 
Around 30% of patients undergoing non-cardiac surgery sustain clinically asymptomatic 
myocardial injury, which is strongly associated with mortality during hospital 
admission.1-3 Myocardial injury is more likely to occur in patients with preoperative 
cardiac vagal (parasympathetic) dysfunction, identified by impaired heart rate recovery 
after exercise.4 Cardiac vagal autonomic impairment is a common feature in 
deconditioned surgical patients,5-7 in whom preoperative cardiopulmonary exercise 
testing also reveal physiological features of cardiac failure including lower peak oxygen 
consumption and higher resting heart rate.8  
 While cardiac vagal activity reduces heart rate after exercise, maximal aerobic 
exercise is facilitated by increases in heart rate principally driven by the sympathetic 
nervous system.9-14 The impaired ability to increase heart rate,4 which is required for 
increased activity or demand, is broadly defined as chronotropic incompetence (CI).12 In 
cardiac failure, high circulating levels of catecholamines result in decreased β-
adrenoceptor density and desensitization, which limit β-agonist mediated contractility.15 
Consequently, CI is a robust predictor of mortality in patients with overt, clinically 
diagnosed cardiac failure.12  
Here, we hypothesised that chronotropic incompetence identified during 
preoperative cardiopulmonary exercise testing was associated with myocardial injury 
within three days after non-cardiac surgery. To identify the relative contributions of 
sympathetic versus parasympathetic activity associated with myocardial injury, we also 
compared the relationship between heart rate increase to, and recovery from, exercise and 
myocardial injury. 
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Methods 
Study design and setting 
This was a pre-defined secondary analysis of the Measurement of Exercise Tolerance 
before Surgery (METS) study, an international prospective observational cohort study of 
preoperative assessment before non-cardiac surgery at twenty-five hospitals in the United 
Kingdom, Canada, New Zealand and Australia. The study protocol and the main study 
results were published previously.2, 16 Research ethics committees reviewed the study and 
it was conducted in accordance with the principles of the Declaration of Helsinki and the 
Research Governance Framework. 
 
Participants  
Participants were aged 40 years or older, undergoing elective non-cardiac surgery under 
general anaesthesia and/or regional anaesthesia with a planned overnight stay in hospital, 
and with at least one of the following perioperative risk factors: intermediate or high-risk 
surgery, coronary artery disease, heart failure, cerebrovascular disease, diabetes mellitus, 
preoperative renal insufficiency, peripheral arterial disease, hypertension, a history of 
tobacco smoking within the previous year or be aged 70 years or more. The exclusion 
criteria were: planned procedure using only endovascular technique, use of 
cardiopulmonary exercise testing for risk stratification as part of routine care, insufficient 
time for cardiopulmonary exercise testing before surgery, presence of an implantable 
cardioverter-defibrillator, known or suspected pregnancy, previous enrolment in the 
study, severe hypertension (>180/100 mmHg), active cardiac conditions or other 
contraindications precluding cardiopulmonary exercise testing.16, 17 Participants gave 
written informed consent to take part before surgery.  
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Study conduct and data collection 
Researchers collected data directly from participants and their medical record. A detailed 
and standardised dataset was collected before surgery, during the hospital stay, and after 
surgery. One year after surgery, participants were contacted by telephone and underwent 
a short interview. Each participant underwent cardiopulmonary exercise testing and had 
blood sampled for NT pro-BNP before surgery, and routine blood sampling for cardiac 
troponin on the first, second and third day after surgery. 
 
Cardiopulmonary exercise testing (CPET) 
Participants underwent preoperative symptom-limited cardiopulmonary exercise testing 
(CPET) using a standardised incremental ramp protocol using electromagnetically-braked 
cycle ergometers.18 The test protocol consisted of spirometry in the seated position, 
followed by three minutes of rest sitting on the ergometer, followed by three minutes of 
unloaded pedalling, followed by pedalling with progressively increasing workload. Once 
the participant reached their peak performance, the exercise test was stopped, the 
workload reduced to 20W and the participant continued to pedal for five minutes in order 
to warm-down. Participants were encouraged to pedal at a steady rate of 60 revolutions 
per minute. Work rates increased by 10W per minute in untrained participants, and by 20-
30W per minute in trained participants or those undertaking regular physical activity 
according to a specific algorithm. Cardiopulmonary function was monitored continuously 
via electrocardiogram, pulse-oximetry and breath-by-breath measurement of minute 
ventilation, carbon dioxide production and oxygen consumption. Non-invasive blood 
pressure was monitored every three minutes.  Investigators at each site interpreted each 
CPET and collected a standardised data set. Peak oxygen consumption was calculated as 
the mean oxygen consumption during the final twenty seconds of incremental exercise.19 
The anaerobic threshold was identified using the modified V-Slope method, followed by 
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the ventilatory equivalent and excess carbon dioxide methods.20 Clinicians at each site 
were blinded to the results of cardiopulmonary exercise testing, except where there was a 
safety concern according to pre-defined criteria.16 
 
Exposures  
The exposure of interest was chronotropic incompetence, defined as chronotropic index 
<0.6 (CI<0.6) using the method described by Dobre et al.21 This threshold is 
prognostically associated with mortality in patients with severe heart failure.21 
Chronotropic index is the ratio of measured increase in heart rate during exercise to the 
age-predicted maximal increase in heart rate.12 Heart rate was measured at rest and at 
peak oxygen consumption during CPET to give the measured increase in heart rate. The 
most widely accepted method for calculating age-predicted maximal heart rate is 220-
age, as described by Astrand.12, 22 Chronotropic index for the main analysis was 
calculated using the formula: 
Chronotropic index = [peak heart rate – resting heart rate] / [age predicted 
maximal heart rate – resting heart rate] 
However, since various population-dependent thresholds have been derived,23 it has been  
suggested to use a CI equation generated in a population most closely matching the 
population of interest. The equation suggested by Tanaka is recommended for apparently 
healthy persons, while other equations are recommended for those with known or 
suspected cardiovascular disease. In this study, we primarily used the Astrand method, 
and supplemented this with two post-hoc sensitivity analyses. Firstly, calculated CI using 
the Tanaka method and second using CI (Astrand) as a continuous variable.24  
 
Primary outcome 
The primary outcome measure was myocardial injury, defined as blood troponin T or I 
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concentration greater than the limit of the reference range (99th centile) for each assay, 
within 72 hours after surgery. Troponin assays differed between participating hospitals 
and are listed in supplementary table 1. The secondary outcome was all-cause mortality at 
one-year after surgery. Additional pre-defined explanatory outcomes were: preoperative 
NT pro-BNP >300pmol/L, a threshold used to predict postoperative cardiovascular 
events in surgical patients25 and heart failure in community cohorts,26 and preoperative 
CPET-derived markers of sub-clinical heart failure (VE/VCO2 ≥34, VO2peak 
≤14ml.kg.min-1, and heart rate recovery ≤ 6 beats per minute at one minute after the end 
of exercise).27 
 
Statistical analysis 
We used STATA version 14 (STATACorp LP, Texas, USA) to analyse the data. We 
excluded the small number of participants without a record of the exposure or outcome. 
We ranked the sample by chronotropic index and dichotomised it according to a threshold 
of <0.6 (CI<0.6), to define groups with and without chronotropic incompetence. We 
presented baseline characteristics for the whole cohort and stratified by chronotropic 
incompetence. Firstly, we used univariable logistic regression analysis to test for 
association between chronotropic incompetence and myocardial injury. Second, we 
constructed multivariable logistic regression models, adjusted for covariates that are 
known to be associated with perioperative myocardial injury and routinely used for 
preoperative risk assessment: age >70 years, male gender, preoperative renal 
insufficiency, peripheral vascular disease, existing diagnosis of heart failure, coronary 
artery disease, hypertension, diabetes mellitus, obstructive lung disease, cerebrovascular 
disease, high-risk surgery and pre-existing atrial fibrillation.28-33 We used backwards 
stepwise selection to identify variables for inclusion in the final model, with a type one 
error threshold of <0.1. Missing data were handled by list-wise deletion. The results of 
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logistic regression analyses were presented as odds ratios (OR) with 95% confidence 
intervals. Normally distributed data were expressed as mean ± standard deviation (SD) 
and non-normally distributed data were expressed as median ± interquartile range (IQR). 
Binary data were expressed as percentages. The threshold for statistical significance was 
p≤ 0.05. 
 
Secondary analyses 
We repeated the primary analysis using mortality within one year after surgery, a binary 
categorical variable, as the outcome measure. We previously described a relationship 
between preoperative resting heart rate and sub-clinical heart failure.27  To explore 
whether chronotropic incompetence is associated with a phenotype of heart failure in this 
cohort, we repeated the primary analysis using the following outcome measures, which 
are biomarkers known to be predictive of poor clinical outcome in overt heart failure: NT 
pro-BNP >300pmol/L, VO2 peak ≤14 ml/kg/min, VE/VCO2 at the anaerobic threshold 
≥34 and heart rate recovery ≤ 6 beats per minute.27  
 
We have previously demonstrated that parasympathetic autonomic dysfunction is 
associated with myocardial injury.[BJA in press] In order to draw direct comparisons 
between sympathetic and parasympathetic dysfunction, we examined the prevalence of 
physiological markers of impaired sympathetic and parasympathetic function using 
chronotropic incompetence and heart rate recovery respectively. We used a widely 
accepted definition of parasympathetic dysfunction, heart rate recovery < 12 (HRR<12) 
beats per minute during the first minute after the end of exercise.9   
 
Sensitivity analyses 
Resting heart rate and the heart rate response to exercise can be influenced by 
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medications such as beta-blockers and rate-limiting calcium channel antagonists, which 
may influence the results of our analysis. We handled this in three ways. First, we 
repeated the primary analysis including beta-blockers and diltiazem/verapamil as 
covariates in the multivariable model. Second, we repeated the primary analysis 
excluding patients receiving beta-blocker and diltiazem/verapamil. Third, we examined 
whether the use of beta-blockade/calcium channel blocker altered participants’ ability to 
exceed a RER>1.05, since RER<1.05 indicates submaximal effort, or that the test was 
terminated prematurely.12  
Our main analysis used the Astrand method. We also performed a post-hoc 
sensitivity analysis, which repeated the primary analysis using age-predicted maximal 
heart rate calculated by the Tanaka method, since we suspect that a significant proportion 
of surgical patients have subclinical cardiac failure.27 We primarily defined chronotropic 
incompetence as chronotropic index <0.6, as described in studies of patients with heart 
failure. However, studies in other populations have defined chronotropic incompetence as 
chronotropic index <0.8.34 Therefore we repeated the primary analysis using CI<0.8 as 
the exposure, as well as examining CI as a continuous variable.  
 
Sample size estimation 
As a planned secondary analysis of a prospectively collected data, the sample size was 
determined based on the comparisons being made in the principal analysis which has 
been published previously.35 We estimated that CI may be present in up to ~30% 
participants. Overall, 12.6% of participants in METS sustained perioperative myocardial 
injury. If participants with CI had a higher incidence of ~16%, at least 1305 particpants’ 
data would be required to detect a clinically significant difference (α=0.05; 1-β=80%).     
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Results 
1741 patients were recruited into the METS study between 1st March 2013 and 25th 
March 2016. After predefined exclusions of patients, we analysed data obtained from 
1325 participants (Figure 1). CI<0.6 was present in 396/1325 (29.9%) study participants, 
of whom 816/1325 (61.7%) were male (Table 1). 
 
Markers of severe cardiac failure 
CI<0.6 was associated with elevated preoperative NT pro-BNP >300pg.mL-1 (OR 1.57 
[1.11-2.23]; p<0.01), adjusted for potentially confounding factors.  CI<0.6 was also 
associated with three independent measures of moderate-severe heart failure (table 3). 
CI<0.6 was more commonly found in patients with VE/VCO2 ≥34 (OR 1.40 [1.09-1.81]; 
p<0.01), VO2 peak ≤ 14 (OR 7.57 [5.50-10.43]; p<0.01) and heart rate recovery ≤6 beats 
per minute during the first minute after the end of exercise (OR 2.63 [1.97-3.52]; 
p<0.01).   
 
Primary clinical outcome: myocardial injury 
162/1325 (12.2%) patients sustained myocardial injury within three days after surgery, 
which occurred in 50/396 (12.6%) patients with CI <0.6 and 112/928 (12.1%) patients 
with CI≥0.6. There was no difference in the odds of myocardial injury amongst patients 
with CI<0.6 compared to those with CI>0.6 (unadjusted OR: 1.05 [0.74-1.50]; p=0.78). 
In the multivariable analysis, CI<0.6 was not associated with myocardial injury (p>0.60). 
 
Secondary outcome: sympathetic versus parasympathetic measures and myocardial 
injury 
We examined the prevalence of physiological markers of impaired sympathetic and 
parasympathetic function using chronotropic incompetence and heart rate recovery 
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respectively. We found that 169 (12.8%) had low CI alone, 294 (22.2%) had HRR<12 
alone, and 227 (17.2%) had both HRR<12 and CI<0.6. When we repeated the primary 
analysis using HRR<12 and CI<0.6 as the exposures, we found that only HRR<12 was 
associated with myocardial injury (sup. table 1). 
 
Secondary outcome: postoperative mortality 
33/1325 (2.5%) patients died within 1 year of surgery. On univariable analysis, 
postoperative mortality was more frequent amongst patients with CI<0.6 (16/396 [4.0%]) 
compared to patients without CI<0.6 (17/928 [1.8%]; unadjusted odds ratio [OR] 2.26 
[1.13-4.51]; p=0.02. However, on multivariable analysis, CI<0.6 and mortality were not 
associated (OR 1.98 [0.97-4.02]; p=0.06; table 2 and figure 2).  
 
Sensitivity analyses 
When we repeated the primary and secondary analysis including preoperative use of beta-
blockers, diltiazem or verapamil as covariates, the results were very similar (sup. table 2). 
Similar proportions of patients receiving these drugs achieved RER >1.05. When we 
repeated the primary analysis excluding patients receiving beta-blockers, diltiazem or 
verapamil CI<0.6 was not associated with myocardial injury (OR 7.20 [0.60 – 87.02]; 
p=0.12) in univariable analysis. The multivariable model did not converge due to 
collinearity between variables. We could not complete regression analysis for mortality 
because an insufficient number of patients died. When we repeated the primary analysis 
using age-predicted maximum heart rate calculated using the method described by 
Tanaka et al, CI<0.6 was not associated with myocardial injury (OR 1.10 [0.78-1.53]; 
p=0.59) or mortality (OR 1.50 [0.75-2.99]; p=0.25) on univariable analysis. In 
multivariable analysis, CI<0.6 was removed from the stepwise models at the p>0.56 level 
for both outcomes. When we repeated the analysis using CI<0.8 as the exposure, CI<0.8 
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was not associated with myocardial injury (OR 0.87 [0.62-1.21]; p=0.41) or mortality 
(OR 1.15 [0.56-2.36]; p=0.70) on univariable analysis. In multivariable analysis, CI<0.8 
was removed from the stepwise model at the p>0.19 level (myocardial injury) and the 
p>0.97 level (mortality). When we repeated the analysis using CI as a continuous 
variable, CI was not associated with myocardial injury (OR 1.20 (0.68-2.09); p 0.53) or 
mortality (OR 0.78 (0.38-1.62); p0.51). 
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Discussion 
The principal finding of this analysis was that preoperative chronotropic incompetence – 
an impaired ability to increase heart rate in response to exercise - was not associated with 
myocardial injury within three days after surgery. By comparing sympathetic versus 
parasympathetic activity during exercise, heart rate recovery, rather than increase, was 
associated with myocardial injury. We also confirmed the deconditioned phenotype of 
subclinical cardiac failure in preoperative patients, since chronotropic incompetence was 
associated with elevated preoperative NT pro-BNP, a preoperative risk factor for 
postoperative cardiovascular morbidity and a biomarker for heart failure in the general 
population. Moreover, a strong association between chronotropic incompetence and 
CPET-derived markers for heart failure.27, 36 These data confirm our previous findings in 
a large prospective cohort that almost one third of patients undergoing non-cardiac 
surgery exhibit a clinical phenotype of sub-clinical cardiac failure that is frequently 
accompanied by significant autonomic impairment.27, 32  
We defined chronotropic incompetence using an established threshold of 
chronotropic index, which is prognostically associated with increased mortality in 
longitudinal cohorts of patients with heart failure.21 Our results do not support a link 
between beta-adrenoceptor dysfunction, as identified using chronotropic incompetence, 
and myocardial injury.  The inability to increase heart rate in patients with CI suggests 
that a direct link between heart rate-demand mismatch is unlikely to underpin myocardial 
injury. However, it is plausible that CI could promote myocardial injury through indirect 
links. The failure to increase cardiac output under certain perioperative circumstances, 
which requires heart rate elevation, may promote hypotensive episodes linked to 
myocardial injury as indicated by the POISE trial of metoprolol.37 Similarly, failure to 
meet metabolic demands during surgery may drive organ injury, which in turn could 
increases the risk of myocardial injury.  The precise mechanism leading to a decrease in 
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β1-adrenergic receptor expression and desensitisation in cardiac failure is unclear, but 
may involve oxidative stress38 driven by chronic systemic inflammation.39 Our finding 
that chronotropic incompetence is associated with reduced survival after non-cardiac 
surgery is consistent with similar observations in patients with heart failure,12, 21, 22, 40-42 
supporting the hypothesis that there is a cohort of surgical patients with severe, yet sub-
clinical, heart failure.27 
A notable strength of our study is that the results have high external validity due to 
the prospective, international, multi-centre nature of the study cohort, which makes our 
findings readily generalisable to the majority of intermediate and high-risk surgical 
patients. The primary outcome, myocardial injury, is an objective, biomarker defined 
endpoint and not subject to observer bias. Clinicians at each participating hospital were 
blinded to the results of the preoperative cardiopulmonary exercise tests. Therefore, 
measurement of chronotropic incompetence did not influence perioperative care.  
Our analysis also has several limitations. Due to the observational study design, we 
are unable to draw conclusions regarding potential causal association between 
chronotropic incompetence and either myocardial injury or mortality.  As with any 
observational study, it is possible that our results may be influenced by unmeasured 
confounding. The primary outcome was myocardial injury and the sample size for the 
study, which was based on cardiovascular outcomes, was appropriate for this outcome. 
However, the study was not powered to detect differences in mortality and therefore we 
advise that inferences regarding mortality should be with caution.   
It is possible that our results could have been influenced by the definition of 
chronotropic incompetence. We defined this as chronotropic index <0.6, which is a poor 
prognostic indicator in patients with heart failure.27 However, some studies in other 
populations have used a different threshold of CI<0.8.34 When we repeated the analysis 
using CI<0.8, the results were very similar. Chronotropic index was calculated as the 
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proportion of age-predicted maximum heart rate reached during preoperative exercise. As 
with any pragmatic study of exercise, there is an underlying assumption that the heart rate 
recorded at peak exertion is an accurate measure of maximal heart rate. Due to the 
clinical nature of the study, we were unable to confirm this with repeated measurements, 
so there is a possibility that some measurements of maximum heart rate might not 
represent true maximal values. However, more than 80% of the cohort achieved an end-
exercise respiratory exchange ratio of >1.05, which is generally accepted to represent 
peak effort.12  
There are several methods for calculating age-predicted maximum heart rate, which 
could potentially influence the results. We chose the method described by Astrand, which 
is the most widely accepted, as the primary method.24 However, we recalculated age-
predicted maximum heart rate using the Tanaka method and the results were very 
similar.23 When we repeated the analysis using chronotropic index as a continuous 
variable, we did not identify a relationship with myocardial injury. However, this method 
assumes a linear relationship between chronotropic index and the risk myocardial injury, 
which may not be true.  
Resting heart rate or change in heart rate may be influenced by rate-limiting 
medications. However, when we repeated the analysis after removing the 224 patients 
receiving beta-blocker or rate-limiting calcium channel antagonists, our results were 
similar. We also repeated multivariable analysis including treatment with beta-blockers or 
rate-limiting calcium channel anatagonists as separate terms in the model and our results 
were very similar. Cardiopulmonary exercise tests were conducted and interpreted by 
investigators at 24 participating hospitals, so there is potential for observer bias and/or 
measurement error between centres. However, this was mitigated through the prospective 
use of a standardised cardiopulmonary exercise test protocol and case report form.16 It is 
possible that a potential relationship between chronotropic incompetence and myocardial 
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injury may have been confounded by intraoperative hypotension. However, when we 
repeated the primary analysis adding intraoperative vasopressor use (a surrogate marker 
of hypotension) as a covariate, the results were unchanged. 
 
Conclusion 
Chronotropic incompetence was associated with both impaired 
cardiopulmonary/autonomic function and elevated NT pro-BNP (indicating sub-clinical 
heart failure). However, in contrast to parasympathetic measures, CI was not linked to 
myocardial injury. These data suggest that a mechanistic role for sympathetic 
dysregulation in myocardial injury is unlikely, and adds further support to the hypothesis 
that cardiac vagal dysfunction is the predominant autonomic influence in determining 
myocardial injury and perioperative outcome.5, 27, 32, 33, 43, 44 
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Table 1. Baseline patient characteristics. 
Descriptive data stratified by preoperative chronotropic incompetence (defined as 
chronotropic index [CI] <0.6). Data are presented as frequencies with percentages 
(%) or means with standard deviations (SD). Continuous data are reported to one 
decimal place and categorical data are rounded to the nearest whole number. ASA 
= American Society of Anesthesiologists. 
 
  Whole cohort CI<0.6 CI≥0.6 
Number of cases (n) 1324 396 928 
Mean age (SD) 64.2 (10.4) 64.8 (10.5) 64.0 (10.3) 
Age ≥70 years (%) 447 (33.8) 149 (37.6) 298 (32.1) 
Male sex (%) 817 (61.7) 236 (59.6) 581 (62.6) 
Comorbid disorder (%) 
   Atrial fibrillation 50 (3.8) 23 (5.8) 27 (2.9) 
Diabetes mellitus 243 (18.4) 90 (22.7) 153 (16.5) 
Hypertension 725 (54.8) 238 (60.1) 487 (52.5) 
Diagnosis of congestive cardiac failure 16 (1.2) 10 (2.5) 6 (0.7) 
Coronary artery disease 153 (11.6) 72 (18.2) 81 (8.7) 
Peripheral vascular disease 39 (3.0) 18 (4.6) 21 (2.3) 
Previous stroke or transient ischaemic attack 52 (3.9) 25 (6.3) 27 (2.9) 
Chronic obstructive pulmonary disease 
(COPD) 163 (12.3) 74 (18.7) 89 (9.6) 
Preoperative eGFR <60ml/min/1.73m2 108 (8.2) 45 (11.4) 63 (6.8) 
Surgical procedure type(%) 
   Vascular  23 (1.7) 12 (3.0) 11 (1.2) 
Intra-peritoneal or retroperitoneal 29 (2.2) 5 (1.3) 24 (2.6) 
Urological or gynaecological 437 (33.0) 131 (33.1) 306 (33.0) 
Intra-thoracic 306 (23.3) 107 (27.0) 199 (21.4) 
Orthopeadic 398 (30.1) 106 (26.8) 292 (31.5) 
Head and neck 87 (6.6) 23 (5.8) 64 (6.9) 
Other 39 (3.0) 11 (2.8) 28 (3.0) 
High-risk surgery (%) 756 (57.1) 221 (55.8) 535 (57.7) 
ASA grade (%) 
   I 99 (7.5) 24 (6.1) 75 (8.1) 
II 772 (58.4) 207 (52.3) 565 (61.0) 
III 433 (32.8) 159 (40.2) 274 (29.6) 
IV 18 (1.4) 6 (1.5) 12 (1.3) 
Preoperative medication (%) 
   Beta-blockers 213 (16.1) 137 (34.6) 76 (8.2) 
Diltiazem or Verapamil 25 (1.9) 11 (2.8) 14 (1.5) 
Haemodynamic variables    
Resting heart rate (beats per minute) 77 (14.3) 75 (15.2) 78 (3.7) 
Resting systolic blood pressure (mmHg) 129 (18.1) 127 (9.0) 130 (17.6) 
Resting pulse pressure (mmHg) 51 (16.5) 51 (17.9) 52 (15.8) 
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Table 2. Chronotropic Incompetence and one-year mortality. 
The independent variable was chronotropic incompetence (defined as chronotropic 
index [CI] <0.6). The dependent variable was mortality within the one-year follow-
up period. Results of two separate analyses are presented. First, univariable 
(unadjusted) logistic regression analysis. Second, multivariable logistic regression 
adjusting for three variables found to be associated with the dependent variable. 
The following variables were excluded from the final multivariable model: diabetes 
mellitus, peripheral vascular disease, atrial fibrillation, high-risk surgery, previous 
stroke or transient ischaemic attack, clinical diagnosis of heart failure, and 
preoperative renal insufficiency. Results are presented as odds ratios with 95% 
confidence intervals and associated p-values. Transient Ischaemic Attack (TIA); 
Chronic Obstructive Pulmonary Disease (COPD). 
  Mortality 
Covariates odds ratio p-value 
Univariable analysis 
  Chronotropic Incompetence 2.26 (1.13-4.51) 0.02 
   Multivariable analysis   
Male sex 2.22 (0.98-5.03) 0.06 
History of stroke or TIA 3.00 (0.99-9.03) 0.05 
History of COPD 2.61 (1.17-5.86) 0.02 
CI <0.6 1.98 (0.97-4.02) 0.06 
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Table 3. Chronotropic incompetence and markers of heart failure. 
The independent variable was chronotropic incompetence (defined as chronotropic index [CI] <0.6). The dependent variables were NT 
pro-BNP >300 pg.mL-1, ventilatory equivalent for carbon dioxide (VE/VCO2) at the anaerobic threshold ≥ 34, peak oxygen consumption 
(VO2) ≤ 14ml/kg/minute and heart rate recovery (HRR) ≤6 beats per minute within the first minute after the end of exercise. Results of 
univariable (unadjusted) and multivariable (adjusted) logistic regression analyses are presented as odds ratios with 95% confidence 
intervals and associated p-values. Variables were selected for inclusion in the multivariable model using stepwise selection. Chronic 
Obstructive Pulmonary Disease (COPD); Transient Ishcaemic Attack (TIA). 
  
NT pro-BNP >300 
pmol/L VE/VCO2 ≥ 34 
VO2 peak ≤14 
ml/kg/min HRR ≤6bpm 
Covariates odds ratio 
p-
value odds ratio 
p-
value odds ratio 
p-
value odds ratio 
p-
value 
Univariable analysis 
        
CI <0.6 2.11 (1.56-2.86) <0.01 
1.57 (1.23-
2.00) <0.01 
6.44 (4.82-
8.59) <0.01 
2.81 (2.11-
3.74) <0.01 
         Multivariable analysis 
        
Age ≥70 years 2.82 (2.01-3.95) <0.01 
2.58 (2.02-
3.29) <0.01 
1.33 (0.95-
1.84) 0.09 
1.53 (1.13-
2.05) <0.01 
Male sex - - 
0.55 (0.44-
0.71) <0.01 
0.17 (0.12-
0.23) <0.01 
0.63 (0.47-
0.84) <0.01 
History of atrial fibrillation 
11.43 (5.71-
22.88) <0.01 - - - - - - 
History of heart failure 7.42 (2.01-27.40) <0.01 - - - - - - 
History of coronary artery disease 2.56 (1.67-3.93) <0.01 - - - - - - 
History of peripheral vascular disease - - - - 
2.62 (1.20-
5.73) 0.02 - - 
History of hypertension 1.46 (1.02-2.10) 0.04 - - - - - - 
History of stroke or TIA - - - - - - - - 
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History of COPD - - 
1.36 (0.96-
1.93) 0.08 - - - - 
History of diabetes - - 
1.31 (0.97-
1.77) 0.08 - - 
1.46 (1.02-
2.07) 0.04 
Preoperative eGFR 
<60ml/min/1.73m2 3.68 (2.29-5.91) <0.01 
1.67 (1.10-
2.53) 0.02 
1.90 (1.14-
3.15) 0.01 
1.67 (1.05-
2.66) 0.03 
High-risk surgery - - - - 
1.44 (1.05-
1.98) 0.03 - - 
CI <0.6 1.57 (1.11-2.23) 0.01 
1.40 (1.09-
1.81) <0.01 
7.57 (5.50-
10.43) <0.01 
2.63 (1.97-
3.52) <0.01 
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Figure legends 
 
Figure 1. Patient flow diagram showing the number of cases included in the analysis. 
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Figure 2. Kaplan-Meier survival plot for chronotropic incompetence (chronotropic 
index <0.6) versus no chronotropic incompetence (chronotropic index ≥ 0.6). 
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